Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Impact BioMedical Inc. focused on discovery, development, and commercialization of products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States. The company provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology; and Laetose technology that is derived from a unique combination of sugar and inositol, which can inhibit the inflammatory and metabolic response of sugar alone. It also develops functional fragrance formulation, a suite of functional fragrances containing specialized botanical ingredients with application as an antimicrobial, and as an additive in insect repellents, detergents, lotions, shampoo, fabrics, and other substances. In addition, the company develops Equivir/Equivir G technology, a novel blend of polyphenols, which have demonstrated antiviral effects for use in as health supplements and medications. Impact BioMedical Inc. was incorporated in 2018 and is based in Houston, Texas. more
Time Frame | IBO | Sector | S&P500 |
---|---|---|---|
1-Week Return | -4.64% | -3.39% | 0.2% |
1-Month Return | -25.66% | -1.92% | 2.72% |
3-Month Return | -3% | -10.54% | 7.31% |
6-Month Return | -15.67% | -4.47% | 10.44% |
Dec '19 | Dec '21 | Dec '22 | Dec '23 | |||
---|---|---|---|---|---|---|
Total Revenue | - | 50.00K | 50.00K | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true}] | |
Cost of Revenue | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] | |
Gross Profit | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] | |
Gross Margin | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] | |
Operating Expenses | 523.71K | 3.45M | 3.45M | 4.03M | [{"date":"2019-12-31","value":13,"profit":true},{"date":"2021-12-31","value":85.75,"profit":true},{"date":"2022-12-31","value":85.75,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] | |
Operating Income | (523.71K) | (3.40M) | (3.40M) | (4.03M) | [{"date":"2019-12-31","value":-52370500,"profit":false},{"date":"2021-12-31","value":-340400000,"profit":false},{"date":"2022-12-31","value":-340400000,"profit":false},{"date":"2023-12-31","value":-402800000,"profit":false}] | |
Total Non-Operating Income/Expense | - | (4.47M) | (4.47M) | (379.00K) | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-447200000,"profit":false},{"date":"2022-12-31","value":-447200000,"profit":false},{"date":"2023-12-31","value":-37900000,"profit":false}] | |
Pre-Tax Income | (654.02K) | (7.88M) | (7.88M) | (4.41M) | [{"date":"2019-12-31","value":-65402000,"profit":false},{"date":"2021-12-31","value":-787600000,"profit":false},{"date":"2022-12-31","value":-787600000,"profit":false},{"date":"2023-12-31","value":-440700000,"profit":false}] | |
Income Taxes | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] | |
Income After Taxes | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] | |
Income From Continuous Operations | (654.02K) | (7.25M) | (7.25M) | (4.41M) | [{"date":"2019-12-31","value":-65402000,"profit":false},{"date":"2021-12-31","value":-725500000,"profit":false},{"date":"2022-12-31","value":-725500000,"profit":false},{"date":"2023-12-31","value":-440700000,"profit":false}] | |
Income From Discontinued Operations | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] | |
Net Income | (454.44K) | (7.05M) | (7.05M) | (4.34M) | [{"date":"2019-12-31","value":-45443600,"profit":false},{"date":"2021-12-31","value":-705100000,"profit":false},{"date":"2022-12-31","value":-705100000,"profit":false},{"date":"2023-12-31","value":-433600000,"profit":false}] | |
EPS (Diluted) | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] | |
These ratios help you determine the liquidity of the company. Higher is better.
IBO | |
---|---|
Current Ratio | 0.02 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
IBO | |
---|---|
ROA (LTM) | -4.99% |
ROE (LTM) | 3.45% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
IBO | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.40 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.53 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
IBO | |
---|---|
Trailing PE | 22.60 |
Forward PE | NM |
P/S (TTM) | 0.00 |
P/B | 0.85 |
Price/FCF | NM |
EV/R | 0.00 |
EV/Ebitda | 10.21 |
Impact BioMedical, Inc. (IBO) share price today is $2.075
Yes, Indians can buy shares of Impact BioMedical, Inc. (IBO) on Vested. To buy Impact BioMedical, Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in IBO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Impact BioMedical, Inc. (IBO) via the Vested app. You can start investing in Impact BioMedical, Inc. (IBO) with a minimum investment of $1.
You can invest in shares of Impact BioMedical, Inc. (IBO) via Vested in three simple steps:
The 52-week high price of Impact BioMedical, Inc. (IBO) is $3.25. The 52-week low price of Impact BioMedical, Inc. (IBO) is $1.22.
The price-to-earnings (P/E) ratio of Impact BioMedical, Inc. (IBO) is 22.6
The price-to-book (P/B) ratio of Impact BioMedical, Inc. (IBO) is 0.85
The dividend yield of Impact BioMedical, Inc. (IBO) is 0.00%
The market capitalization of Impact BioMedical, Inc. (IBO) is $26.00M
The stock symbol (or ticker) of Impact BioMedical, Inc. is IBO